Showing 2,541 - 2,560 results of 3,407 for search '"amyloid beta"', query time: 0.77s Refine Results
  1. 2541

    Serum metabolomics profiling of commercially mixed functional foods—effects in Beta-amyloid induced rats measured using 1H NMR spectroscopy by Mohd Rosli, Nur Hasnieza, Yahya, Hanis Mastura, Ibrahim, Farah Wahida, Shahar, Suzana, Ismail, Intan Safinar, Ahmad Azam, Amalina, Rajab, Nor Fadilah

    Published 2020
    “…In this novel and original study, an 1H NMR spectroscopy tool was used to identify the metabolic neuroprotective mechanism of commercially mixed functional foods (MFF) consisting of pomegranate, dates and honey, in rats injected with amyloid-beta 1-42 (Aβ-42). Forty-five male albino Wistar rats were randomly divided into five groups: NC (0.9% normal saline treatment + phosphate buffer solution (PBS) solution injection), Abeta (0.9% normal saline treatment + 0.2 µg/µL Aβ-42 injection), MFF (4 mL/kg MFF treatment + PBS solution injection), Abeta-MFF (4 mL/kg MFF treatment + 0.2 µg/µL Aβ-42 injection) and Abeta-NAC (150 mg/kg N-acetylcysteine + 0.2 µg/µL Aβ-42 injection). …”
    Article
  2. 2542

    Asymptomatic neurotoxicity of amyloid β-peptides (Aβ1-42 and Aβ25-35) on mouse embryonic stem cell-derived neural cells by Mansor, Nur Izzati, Ntimi, Carolindah Makena, Abdul Aziz, Noraishah Mydin, Ling, King Hwa, Adam, Aishah, Rosli, Rozita, Hassan, Zurina, Nordin, Norshariza

    Published 2020
    “…One of the strategies in the establishment of in vitro oxidative stress models for neurodegenerative diseases, such as Alzheimer's disease (AD), is to induce neurotoxicity by amyloid beta (Aβ) peptides in suitable neural cells. …”
    Get full text
    Article
  3. 2543

    Topographical patterns of whole-brain structural alterations in association with genetic risk, cerebrospinal fluid, positron emission tomography biomarkers of Alzheimerâs disease,... by Dayor Piersson, Albert, Mohamad, Mazlyfarina, Rajab, Nor Fadilah, Suppiah, Subapriya

    Published 2021
    “…This study aimed at investigating the topographical pattern of whole-brain structural alterations in association with apolipoprotein E e4 (APOE e4), cerebrospinal fluid (CSF) [amyloid-beta 42 (Aβ42), and neurofibrillary tau protein], positron emission tomography (PET) biomarkers [Aβ, tau, and 2-[18F]fluoro-2-deoxy-d-glucose (FDG)], and neuropsychological measures. …”
    Article
  4. 2544

    Asymptomatic neurotoxicity of amyloid Î-peptides AÎ1-42 and AÎ25-35 on mouse embryonic stem cell-derived neural cells by Mansor, Nur Izzati, Ntimi, Carolindah Makena, Abdul Aziz, Noraishah Mydin, King, Hwa Ling, Adam, Aishah, Rosli, Rozita, Hassan, Zurina, Nordin, Norshariza

    Published 2021
    “…One of the strategies in the establishment of in vitro oxidative stress models for neurodegenerative diseases, such as Alzheimer's disease (AD), is to induce neurotoxicity by amyloid beta (Aβ) peptides in suitable neural cells. …”
    Article
  5. 2545
  6. 2546

    Quercetin protects human brain microvascular endothelial cells from fibrillar β-amyloid1–40-induced toxicity by Yongjie Li, Sibai Zhou, Jinze Li, Yuhua Sun, Hamlati Hasimu, Rui Liu, Tiantai Zhang

    Published 2015-01-01
    “…Amyloid beta-peptides (Aβ) are known to undergo active transport across the blood-brain barrier, and cerebral amyloid angiopathy has been shown to be a prominent feature in the majority of Alzheimer׳s disease. …”
    Get full text
    Article
  7. 2547

    Longitudinal microbiome investigation throughout prion disease course reveals pre- and symptomatic compositional perturbations linked to short-chain fatty acid metabolism and cogni... by Marco Losa, Marco Losa, Yasser Morsy, Marc Emmenegger, Marc Emmenegger, Salomon M. Manz, Petra Schwarz, Adriano Aguzzi, Michael Scharl

    Published 2024-06-01
    “…They conspicuously impact disease development and progression, including amyloid-beta (Aβ) and alpha (α)-synuclein pathology in neurodegenerative diseases, conveying the importance of the brain–gut–microbiome axis in such conditions. …”
    Get full text
    Article
  8. 2548

    Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration by Marlies Gijs, Inez H. G. B. Ramakers, Pieter Jelle Visser, Frans R. J. Verhey, Marjo P. H. van de Waarenburg, Casper G. Schalkwijk, Rudy M. M. A. Nuijts, Carroll A. B. Webers

    Published 2021-11-01
    “…Tear fluid was collected from a total of 65 subjects, including 23 patients with subjective cognitive decline (SCD), 22 patients with mild cognitive impairment (MCI), 11 dementia patients and 9 healthy controls (HC). Levels of amyloid-beta peptides (AB38, AB40, AB42), total-tau (t-tau) and phosphorylated-tau (p-tau) were determined using multiplex immunoassays. …”
    Get full text
    Article
  9. 2549

    The Oral-Gut-Brain AXIS: The Influence of Microbes in Alzheimer’s Disease by Narengaowa, Wei Kong, Fei Lan, Umer Farooq Awan, Hong Qing, Junjun Ni

    Published 2021-04-01
    “…Neurofibrillary tangles and the deposition of amyloid-beta (Aβ) protein are typical pathological features and fundamental causes of cognitive impairment in AD patients. …”
    Get full text
    Article
  10. 2550

    Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β by Rebecca Faresjö, Elisabet O. Sjöström, Tiffany Dallas, Magnus M. Berglund, Jonas Eriksson, Dag Sehlin, Stina Syvänen

    Published 2024-12-01
    “…We developed and evaluated fusion proteins (FPs) combining VHHs with human IgG Fc domains or single-chain variable fragments (scFvs) of the anti-amyloid-beta (Aβ) antibody 3D6. In vitro assessments showed varying affinities of the FPs for TfR. …”
    Get full text
    Article
  11. 2551

    Cardiac functional and structural impairments, endothelial apoptosis and blood-brain barrier dysfunction in models of cerebrovascular amyloidosis in the presence or absence of hype... by Ashley Carey, Andrea Elia, Rebecca Parodi-Rullan, Silvia Fossati

    Published 2024-01-01
    “…Recent evidence suggests that cardiovascular (CV)/cerebrovascular risk factors, such as hyperhomocysteinemia (Hhcy) contribute to increasing AD pathology and risk, but it remains unknown whether Amyloid beta (Aβ) and homocysteine function through common molecular mechanisms to induce EC dysfunction. …”
    Get full text
    Article
  12. 2552

    Acute exercise and brain BACE1 protein content: a time course study by Alex J. Yang, Grant C. Hayward, Rebecca E. K. MacPherson

    Published 2019-04-01
    “…The rate limiting enzyme in the production of amyloid‐beta peptides, BACE1, was reduced in the prefrontal cortex 2 h post‐exercise, however if these effects remain over time is unknown. …”
    Get full text
    Article
  13. 2553

    Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls. by Johannes Denk, Felix Oberhauser, Johannes Kornhuber, Jens Wiltfang, Klaus Fassbender, Matthias L Schroeter, Alexander E Volk, Janine Diehl-Schmid, Johannes Prudlo, Adrian Danek, Bernhard Landwehrmeyer, Martin Lauer, Markus Otto, Holger Jahn, FTLDc study group

    Published 2018-01-01
    “…Correlation analysis revealed that miRNAs from the 3-factor model also correlated with levels of protein biomarker amyloid-beta1-42 and phosphorylated neurofilament heavy chain, indicating their potential role in the monitoring of progressive neuronal degeneration. …”
    Get full text
    Article
  14. 2554

    Optimization of Culture Conditions for High Cell Productivity and Astaxanthin Accumulation in Vietnam’s Green Microalgae <i>Haematococcus pluvialis</i> HB and a Neuroprotective Act... by Nguyen Cam Ha, Luu Thi Tam, Hoang Thi Minh Hien, Ngo Thi Hoai Thu, Dang Diem Hong, Le Thi Thom

    Published 2024-11-01
    “…It also showed neuroprotective effects against H<sub>2</sub>O<sub>2</sub> and amyloid beta-induced neurotoxicity in C6 cells. Conclusions: This study highlights <i>H. pluvialis</i> HB as a promising source for large-scale astaxanthin production with potential applications in neuroprotective health products.…”
    Get full text
    Article
  15. 2555

    Differential blood-based biomarkers of subcortical and deep brain small vessel disease by Pablo Hervella, Maria Luz Alonso-Alonso, Ana Sampedro-Viana, Manuel Rodríguez-Yáñez, Iria López-Dequidt, José M. Pumar, Alberto Ouro, Daniel Romaus-Sanjurjo, Francisco Campos, Tomás Sobrino, José Castillo, Yago Leira, Ramón Iglesias-Rey

    Published 2024-05-01
    “…Methods: We examined the relationship between Alzheimer’s disease biomarkers [amyloid beta (Aβ 1–40 , Aβ 1–42 )], serum inflammatory marker (interleukin-6, IL-6), and endothelial dysfunction markers [soluble tumor necrosis factor-like weak inducer of apoptosis, and pentraxin-3 (sTWEAK, PTX3)] with respect to LS occurring in deep brain structures and subcortical white matter. …”
    Get full text
    Article
  16. 2556

    Formaldehyde initiates memory and motor impairments under weightlessness condition by Tianhao Mei, Ying Chen, Yajuan Gao, Hang Zhao, Xingzhou Lyu, Jing Lin, Tianye Niu, Hongbin Han, Zhiqian Tong

    Published 2024-10-01
    “…However, excessive FA has the potential to form cross-links between these two proteins and amyloid-beta (Aβ), thereby obstructing ECS and inducing neuron death. …”
    Get full text
    Article
  17. 2557

    Discovery of Novel Drug Candidates for Alzheimer’s Disease by Molecular Network Modeling by Jiaxin Zhou, Qingyong Li, Wensi Wu, Xiaojun Zhang, Zhiyi Zuo, Yanan Lu, Huiying Zhao, Zhi Wang

    Published 2022-04-01
    “…Pretreatment with GHK showed a neuroprotective effect against amyloid-beta-induced injury in differentiated human neuron-like SH-SY5Y cells. …”
    Get full text
    Article
  18. 2558

    Yeast-Based Aβ1-15 Vaccine Elicits Strong Immunogenicity and Attenuates Neuropathology and Cognitive Deficits in Alzheimer’s Disease Transgenic Mice by Dong-qun Liu, Shuai Lu, Lun Zhang, Ya-ru Huang, Mei Ji, Xiao-ying Sun, Xiao-ge Liu, Rui-tian Liu

    Published 2020-07-01
    “…Immunotherapy focusing on reducing the amyloid-beta (Aβ) burden is a promising treatment strategy for Alzheimer’s disease (AD). …”
    Get full text
    Article
  19. 2559

    Coupling of the spatial distributions between sMRI and PET reveals the progression of Alzheimer’s disease by Kun Zhao, Jiaji Lin, Martin Dyrba, Dong Wang, Tongtong Che, Haoyang Wu, Jingyu Wang, Yong Liu, Shuyu Li

    Published 2023-01-01
    “… AbstractAmyloid-beta (Aβ) deposition and altered brain structure are the most relevant neuroimaging biomarkers for Alzheimer’s disease (AD). …”
    Get full text
    Article
  20. 2560

    The canine activated platelet secretome (CAPS): A translational model of thrombin‐evoked platelet activation response by Signe E. Cremer, James L. Catalfamo, Robert Goggs, Stefan E. Seemann, Annemarie T. Kristensen, Paulina B. Szklanna, Patricia B. Maguire, Marjory B. Brooks

    Published 2021-01-01
    “…Among the differences from human platelets were a canine lack of platelet factor 4 and vascular endothelial growth factor C, and a 10‐ to 20‐fold lower concentration of proteins such as haptoglobin, alpha‐2 macroglobulin, von Willebrand factor, and amyloid‐beta A4. Twenty‐eight CAPS proteins, including cytokines, adhesion molecules, granule proteins, and calcium regulatory proteins have not previously been attributed to human platelets. …”
    Get full text
    Article